Prevalence of anti-HCV antibodies in central India.

Simple item page
dc.contributor.authorJaiswal, S Pen_US
dc.contributor.authorChitnis, D Sen_US
dc.contributor.authorNaik, Gen_US
dc.contributor.authorArtwani, K Ken_US
dc.contributor.authorPandit, C Sen_US
dc.contributor.authorSalgia, Pen_US
dc.contributor.authorSepaha, Aen_US
dc.date.accessioned1996-08-01en_US
dc.date.accessioned2009-05-27T07:52:16Z
dc.date.available1996-08-01en_US
dc.date.available2009-05-27T07:52:16Z
dc.date.issued1996-08-01en_US
dc.description.abstractThe study group screened for anti-HCV comprised 789 subjects of hepatitis, renal failure, thalassaemia and healthy voluntary blood donors coming from Central India during July 1992 to November 1995. The prevalence of HCV was low (4.85%) among 103 patients of acute viral hepatitis (AVH) while it was higher (25.64%) among 117 patients of chronic liver disease (CLD) with the highest rate of 31.57 percent in 57 patients of cirrhosis. The anti-HCV positivity among 101 patients with hepatic failure was around 10 percent. High risk groups such as chronic renal failure (CRF) patients mainly on haemodialysis and thalassaemics receiving multiple blood transfusions showed the prevalence of anti-HCV in 41.9 and 25.45 percent respectively. Only 1.78 percent of the 280 voluntary blood donors showed positivity for anti-HCV. Comparison of the data on HCV in the present study with data from other parts of India showed a wide variation in the different centers. The higher prevalence of HCV among CRF patients and thalassaemics indicates the need for screening of the blood units for anti-HCV before transfusion to these high risk patients.en_US
dc.description.affiliationDepartment of Microbiology & Immunology, Choithram Hospital & Research Centre, Indore.en_US
dc.identifier.citationJaiswal SP, Chitnis DS, Naik G, Artwani KK, Pandit CS, Salgia P, Sepaha A. Prevalence of anti-HCV antibodies in central India. Indian Journal of Medical Research. 1996 Aug; 104(): 177-81en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/22386
dc.language.isoengen_US
dc.source.urihttps://icmr.nic.in/ijmr/ijmr.htmen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshBlood Donorsen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshFemaleen_US
dc.subject.meshHepatitis --immunologyen_US
dc.subject.meshHepatitis C --epidemiologyen_US
dc.subject.meshHepatitis C Antibodies --analysisen_US
dc.subject.meshHumansen_US
dc.subject.meshIndiaen_US
dc.subject.meshKidney Failure, Chronic --immunologyen_US
dc.subject.meshMaleen_US
dc.subject.meshMass Screeningen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPrevalenceen_US
dc.subject.meshThalassemia --immunologyen_US
dc.titlePrevalence of anti-HCV antibodies in central India.en_US
dc.typeJournal Articleen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Medical Research